Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 4/20 | 0.83 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.83 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.83 |
| ▸ | SRC | P12931 | 2/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.83 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.83 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.83 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.83 |
| ▸ | LDHA | P00338 | 1/20 | 0.83 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.83 |
| ▸ | FBP1 | P09467 | 1/20 | 0.83 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.83 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.83 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.83 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.83 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.83 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.83 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.83 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.83 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21067751 | 1.00 | P2RY1 (0.83) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| SCHEMBL1061029 | 1.00 | P2RY1 (0.83) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| SCHEMBL29431883 | 1.00 | P2RY1 (0.83) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| SCHEMBL31266503 | 1.00 | P2RY1 (0.83) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| SCHEMBL15498428 | 1.00 | P2RY1 (0.83) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| SCHEMBL23867092 | 1.00 | P2RY1 (0.83) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| Water SCHEMBL17159664 | 0.99 | P2RY1 (0.81) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| Sulfuric Acid SCHEMBL11187808 | 0.96 | P2RY1 (0.77) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| SCHEMBL4360139 | 0.95 | P2RY1 (0.75) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 | |
| SCHEMBL24059958 | 0.94 | ADORA1 (0.76) | P2RY1P2RY2ADORA1SRCSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 817 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| US-20250290051-A1 | MUTATED SULFOTRANSFERASES AND USES THEREOF | SANOFI SA (FR) | 2025-09-18 | — | — | US | claimed |
| WO-2025019764-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | MATTERWORKS INC (US) | 2025-01-23 | — | — | WO | claimed |
| US-20250012802-A1 | SYSTEMS AND METHODS FOR PREDICTING RESPONSE TO ORAL MINOXIDIL FOR THE TREATMENT OF ANDROGENETIC ALOPECIA | FOLLEA INTERNATIONAL | 2025-01-09 | — | — | US | claimed |
| EP-4488388-A1 | SYSTEMS AND METHODS FOR PREDICTING RESPONSE TO ORAL MINOXIDIL FOR THE TREATMENT OF ANDROGENETIC ALOPECIA | Follea International (US) | 2025-01-08 | — | — | EP | claimed |
| WO-2024239431-A1 | METHOD FOR PHOSPHORYLATION OF NUCLEIC ACID AT 3' END AND LIBRARY CONSTRUCTION | 深圳华大智造科技股份有限公司 | 2024-11-28 | — | — | WO | claimed |
| EP-4437319-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | Matterworks Inc (US) | 2024-10-02 | — | — | EP | claimed |
| EP-4408988-A1 | USES AND METHODS FOR SULFATING A SUBSTRATE WITH A MUTATED ARYLSULFOTRANSFERASE | Sanofi (FR) | 2024-08-07 | — | — | EP | claimed |
| EP-4408987-A2 | MUTATED SULFOTRANSFERASES AND USES THEREOF | Sanofi (FR) | 2024-08-07 | — | — | EP | claimed |
| CN-118339282-A | Use and method of sulfating a substrate with a mutated arylsulftransferase | 赛诺菲 | 2024-07-12 | — | — | CN | claimed |
| EP-0739630-B1 | Process for the simultaneous elimination of tumor necrosis factor alpha and bacterial lipopolysaccharides from whole blood and/or blood plasma | BRAUN MELSUNGEN AG (DE) | 2003-03-12 | — | — | EP | claimed |
| US-6436407-B1 | E. COLI HEAT-LABILE ENTEROTOXIN WHICH HAS LOST ITS TOXICITY BUT HAS RETAINED ITS IMMUNOLOGIC ACTIVITY | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND | 2002-08-20 | — | — | US | claimed |
| EP-0592989-B1 | Process of the selective and quantitative removal or preparation of tumor necrosis factor (TNF) and lipopolysaccharides (LPS) of aqueous solutions | BRAUN MELSUNGEN AG (DE) | 2002-05-08 | — | — | EP | claimed |
| US-6372724-B1 | MODULATING HISTAMINE RELEASE; CONTACTING MAST CELLS WITH AGENT WHICH INHIBITS ADENOSINE TRIPHOSPHATE (ATP) FROM BINDING TO P2-PURINOCEPTORS; TREATING ASTHMA AND ALLERGIES | DUSKA SCIENTIFIC CO. | 2002-04-16 | — | — | US | claimed |
| US-6255088-B1 | Enzymatic sulfation of biomolecules | THE SCRIPPS RESEARCH INSTITUTE | 2001-07-03 | — | — | US | claimed |
| EP-0693553-B1 | Heparan sulfate 6-0-sulfotransferase | SEIKAGAKU KOGYO CO LTD (JP) | 1998-10-14 | — | — | EP | claimed |
| EP-0739630-A2 | Process and apparatus for the simultaneous elimination of tumor necrosis factor aplha and bacterial lipopolysaccharides from whole blood and/or blood plasma | B. BRAUN MELSUNGEN AG (DE) | 1996-10-30 | — | — | EP | claimed |
| EP-0592989-A2 | Process of the selective and quantitative removal or preparation of tumor necrosis factor (TNF) and/or lipopolysaccharides (LPS) of aqueous solutions | B. BRAUN MELSUNGEN AG (DE) | 1994-04-20 | — | — | EP | claimed |
| EP-0178113-B1 | REAGENT FOR ASSAYING CREATINE KINASE | UNITIKA LTD. (JP) | 1989-05-03 | — | — | EP | claimed |
| US-4157440-A | TREATMENT OF CARDIAC HYPERTROPHY; REACTION OF GLUCOSAMINE WITH CAMP | MARXER S.P.A. (IT) | 1979-06-05 | — | — | US | claimed |